首页 | 本学科首页   官方微博 | 高级检索  
检索        


Amyloid β protein 1–42/43 (Aβ 1–42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study
Authors:Akira Tamaoka  Naoya Sawamura  Asano Odaka  Nobuhiro Suzuki  Hidehiro Mizusawa  Shin'ichi Shoji  Hiroshi Mori
Institution:aDepartment of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba ,Japan;bDiscovery Research Division, Takeda Chemical Industries, Tsukuba ,Japan;cDepartment of Molecular Biology, Tokyo Institute of Psychiatry, Tokyo ,Japan
Abstract:Diffuse plaques are immature and amorphous senile plaques and believed to be in the initial phase of plaque formation. In contrast to amyloid angiopathy and the plaque core amyloid, diffuse plaques failed to be purified in preserved forms from the brain. Here, we studied the diffuse plaques in the cerebellar region of the Alzheimer's disease brain based on immunocytochemistry and ELISA using two different monoclonal antibodies specifically recognizing the car?yl termini of Aβ molecules (BA27 for Aβ 1–40 and BC05 for Aβ 1–42/43). We found that the amount of Aβ 1–40 was in proportion to the staining degree on amyloid angiopathy by immunohistochemistry. We found that Aβ 1–42/43 comprised diffuse plaques as the major component in the cerebella of AD brains. Taking these findings into consideration, diffuse plaques, the earliest pathological change in the brain with AD, are concluded to be composed mainly of Aβ 1–42/43, implicating the critical importance of this kind of Aβ species deposition in the pathogenesis of AD.
Keywords:Alzheimer's disease  Amyloid β protein  Diffuse plaque  Amyloid angiopathy  Cerebellum  Enzyme-linked immunosorbent assay  Immunocytochemistry
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号